by Kacey Ma | Sep 3, 2021 | News & Announcements
Windgap Medical, Inc. announced today that it has a strategic partnership with ALK-Abelló, A/S (“ALK”) to commercialize the company’s epinephrine autoinjector (EAI) for the treatment of anaphylactic shock. Read the full press release...
